ALLVIVO VASCULAR, INC.
Engineered antimicrobial peptide (ASP-2) for chronic wound treatment that disrupts biofilms and promotes healing
- Sector
- Medtech
- Headquarters
- Lake Forest, CA
- Total capital
- $7.1M
- Federal grants
- $7.1M
- 11 awards · 2015–2025
- Rank in peer group#10 of 41
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2026
- Rank in peer group#13 of 41
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Antimicrobial Treatment to Combat Wound Biofilm$1.0M
- Federal grantHealth and Human S · Phase I · Catheter Cap with Anti-biofilm Luminal Insert$296K
- Federal grantHealth and Human S · Phase II · Antimicrobial Treatment to Combat Wound Biofilm$1.0M
- Federal grantHealth and Human S · Phase II · Antimicrobial Peptide Treatment to Combat Wound Biofilm$646K
- Federal grantHealth and Human S · Phase II · Antimicrobial Peptide Treatment to Combat Wound Biofilm$1.6M
- Federal grantHealth and Human S · Phase II · Antimicrobial Tracheostomy Tube to Prevent Biofilm and Reduce InfectionRisks$591K
- Federal grantHealth and Human S · Phase II · Antimicrobial Tracheostomy Tube to Prevent Biofilm and Reduce InfectionRisks$1.2M
Show 4 earlier federal awards
- Federal grantHealth and Human S · Phase I · Antimicrobial Peptide Treatment to Combat Wound Biofilm$259K
- Federal grantHealth and Human S · Phase I · Antimicrobial Endotracheal Tube to Combat Biofilm$50K
- Federal grantHealth and Human S · Phase I · Antimicrobial Endotracheal Tube to Combat Biofilm$274K
- Federal grantDefense · Phase I · Stabilized Antimicrobial Peptides to Combat Multidrug-Resistant Biofilm$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 41 peers
Line = medianMedtech · Molecule
- Federal grants#10 · top 24%
- Granted patents#13 · top 32%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 4- GrantedDelivery Systems For Administration Of Cationic Biological ActivesUSPTOUS 12,551,596
- PendingSelf Adhesive Film For Delivery Of ActivesUSPTOApplication 16647503
- PendingDelivery Systems For Administration Of Cationic Biological ActivesUSPTOApplication PCTUS2018058298
Show all 4 patent records
- Delivery Systems For Administration Of Cationic Biological ActivesFeb 17, 2026 · US 12,551,596Granted
- Self Adhesive Film For Delivery Of ActivesJul 30, 2020 · Application 16647503Pending
- Delivery Systems For Administration Of Cationic Biological ActivesApplication PCTUS2018058298Pending
- Self Adhesive Film For Delivery Of ActivesApplication PCTUS2018051087Pending
Related companies, and why
- VAYU GLOBAL HEALTH INNOVATIONS, LLCSimilar federal contract value in Medtech · null in contracts
- Adagio MedicalSimilar federal contract value in Medtech · null in contracts
- Francis Medical, Inc.Similar federal contract value in Medtech · null in contracts
- KYPHA INC.Similar federal contract value in Medtech · null in contracts
- Vivifi Medical LLCSimilar federal contract value in Medtech · null in contracts
- WASATCH PHOTONICS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .